A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Danaher Corp stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 3,561 shares of DHR stock, worth $750,445. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,561
Previous 2,725 30.68%
Holding current value
$750,445
Previous $758 Million 7.92%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$226.16 - $274.52 $189,069 - $229,498
836 Added 30.68%
3,561 $818 Million
Q3 2024

Nov 12, 2024

BUY
$239.25 - $280.76 $262,696 - $308,274
1,098 Added 67.49%
2,725 $758 Million
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $170,744 - $194,285
725 Added 80.38%
1,627 $407 Million
Q4 2023

Feb 14, 2024

BUY
$185.1 - $233.13 $166,960 - $210,283
902 New
902 $209 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $153B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Foster Dykema Cabot & Partners, LLC Portfolio

Follow Foster Dykema Cabot & Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & Partners, LLC with notifications on news.